Artur Plawgo When Beam Therapeutics (NASDAQ:BEAM) reported third-quarter results on Nov. 7, 2022, shares briefly rallied. BEAM stock lost momentum at the $50 resistance established in late Sept. 2022. Short sellers are still in control, […]
Ziprecruiter (ZIP) Investor Presentation – Slideshow
Sonoco Products (SON) Investor Presentation – Slideshow
© Copyright 2020-2023 Forex.ca
Please note that foreign exchange and other leveraged trading involves significant risk of loss. It is not suitable for all investors and you should make sure you understand the risks involved, seeking independent advice if necessary.